Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab
Go back to Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab| REPROS THERAPEUTICS (NASDAQ: RPRX) | Delayed: 63.88 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $63.88 | 52 Week High | $3.48 | |||
| Open | $63.88 | 52 Week Low | $0.80 | |||
| Day High | $63.88 | P/E | N/A | |||
| Day Low | $63.88 | EPS | $-1.54 | |||
| Volume | 1,406 | |||||
